BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Greenwald BD, Dumot JA. Cryotherapy for Barrettʼs esophagus and esophageal cancer: . Current Opinion in Gastroenterology 2011;27:363-7. [DOI: 10.1097/mog.0b013e328347bae8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Kristo I, Riegler FM, Asari R, Cosentini E, Schoppmann SF. Selected commentary to “Treatment of Barrett’s esophagus with a novel focal cryoablation device: a safety and feasibility study”. Eur Surg 2015;47:274-8. [DOI: 10.1007/s10353-015-0340-x] [Reference Citation Analysis]
2 Suchniak-Mussari K, Dye CE, Moyer MT, Mathew A, McGarrity TJ, Gagliardi EM, Maranki JL, Levenick JM. Efficacy and safety of liquid nitrogen cryotherapy for treatment of Barrett’s esophagus. World J Gastrointest Endosc 2017; 9(9): 480-485 [PMID: 28979713 DOI: 10.4253/wjge.v9.i9.480] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
3 Rajendra S, Sharma P. Management of Barrett's oesophagus and intramucosal oesophageal cancer: a review of recent development. Therap Adv Gastroenterol. 2012;5:285-299. [PMID: 22973415 DOI: 10.1177/1756283x12446668] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
4 Amadi C, Gatenby P. Barrett’s oesophagus: Current controversies. World J Gastroenterol 2017; 23(28): 5051-5067 [PMID: 28811703 DOI: 10.3748/wjg.v23.i28.5051] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
5 Hasan R, Sharma R, Saraya A, Chattopadhyay TK, DattaGupta S, Walfish PG, Chauhan SS, Ralhan R. Mitogen activated protein kinase kinase kinase 3 (MAP3K3/MEKK3) overexpression is an early event in esophageal tumorigenesis and is a predictor of poor disease prognosis. BMC Cancer 2014;14:2. [PMID: 24383423 DOI: 10.1186/1471-2407-14-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
6 Subramanian CR, Triadafilopoulos G. Endoscopic treatments for dysplastic Barrett's esophagus: resection, ablation, what else? World J Surg 2015;39:597-605. [PMID: 24841804 DOI: 10.1007/s00268-014-2636-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Shah T, Kushnir V, Mutha P, Majhail M, Patel B, Schutzer M, Mogahanaki D, Smallfield G, Patel M, Zfass A. Neoadjuvant cryotherapy improves dysphagia and may impact remission rates in advanced esophageal cancer. Endosc Int Open 2019;7:E1522-7. [PMID: 31681831 DOI: 10.1055/a-0957-2798] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
8 Hammoud GM, Hammad H, Ibdah JA. Endoscopic assessment and management of early esophageal adenocarcinoma. World J Gastrointest Oncol 2014; 6(8): 275-288 [PMID: 25132925 DOI: 10.4251/wjgo.v6.i8.275] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
9 Rouphael C, Anil Kumar M, Sanaka MR, Thota PN. Indications, contraindications and limitations of endoscopic therapy for Barrett's esophagus and early esophageal adenocarcinoma. Therap Adv Gastroenterol 2020;13:1756284820924209. [PMID: 32523628 DOI: 10.1177/1756284820924209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Palma GDD. Management strategies of Barrett's esophagus. World J Gastroenterol 2012; 18(43): 6216-6225 [PMID: 23180941 DOI: 10.3748/wjg.v18.i43.6216] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
11 Genere JR, Visrodia K, Zakko L, Hoefnagel SJM, Wang KK. Spray cryotherapy versus continued radiofrequency ablation in persistent Barrett’s esophagus. Diseases of the Esophagus 2022. [DOI: 10.1093/dote/doab084] [Reference Citation Analysis]
12 Baust JG, Gage AA, Bjerklund Johansen TE, Baust JM. Mechanisms of cryoablation: clinical consequences on malignant tumors. Cryobiology 2014;68:1-11. [PMID: 24239684 DOI: 10.1016/j.cryobiol.2013.11.001] [Cited by in Crossref: 91] [Cited by in F6Publishing: 54] [Article Influence: 10.1] [Reference Citation Analysis]
13 Spiritos Z, Mekaroonkamol P, El-Rayes BF, Force SD, Keilin SA, Cai Q, Willingham FF. Long-Term Survival in Stage IV Esophageal Adenocarcinoma with Chemoradiation and Serial Endoscopic Cryoablation. Clin Endosc 2017;50:491-4. [PMID: 28434215 DOI: 10.5946/ce.2017.006] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]